Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion type Assertion NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_head.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion description "[MEF2A was excluded as a candidate for dilated cardiomyopathy (DCM)(LOD of -9.03) and hypertrophic cardiomyopathy (HCM)(LODs of -5.43 and -2.44) in these families.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion evidence source_evidence_literature NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion SIO_000772 9076715 NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion wasDerivedFrom befree-20140225 NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.
- NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_assertion wasGeneratedBy ECO_0000203 NP618095.RACV9COKgJGbWx1BeURvp4-Rfoijcg-vuGehJWwoLrrfs130_provenance.